1. Home
  2. MQ vs NVCR Comparison

MQ vs NVCR Comparison

Compare MQ & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marqeta Inc.

MQ

Marqeta Inc.

HOLD

Current Price

$3.97

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$17.16

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MQ
NVCR
Founded
2010
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
MQ
NVCR
Price
$3.97
$17.16
Analyst Decision
Hold
Buy
Analyst Count
10
6
Target Price
$5.36
$28.08
AVG Volume (30 Days)
4.5M
1.4M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
$624,884,000.00
$655,353,000.00
Revenue This Year
$16.89
$7.72
Revenue Next Year
$16.36
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
23.25
8.28
52 Week Low
$3.70
$9.82
52 Week High
$7.04
$18.92

Technical Indicators

Market Signals
Indicator
MQ
NVCR
Relative Strength Index (RSI) 47.47 54.86
Support Level $3.81 $12.66
Resistance Level $4.30 $18.80
Average True Range (ATR) 0.19 1.05
MACD -0.00 -0.21
Stochastic Oscillator 34.37 62.75

Price Performance

Historical Comparison
MQ
NVCR

About MQ Marqeta Inc.

Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: